Press release
Investigation announced for Investors in shares of Innate Pharma S.A. (NASDAQ: IPHA)
An investigation for investors in Innate Pharma S.A. (NASDAQ: IPHA) shares over potential securities laws violations.
Investors who purchased shares of Innate Pharma S.A. (NASDAQ: IPHA), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether certain statements by Innate Pharma S.A. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
France based Innate Pharma S.A., a clinical-stage biotechnology company, discovers and develops therapeutic antibodies for the treatment of cancer in France and internationally. Innate Pharma S.A. reported that its annual Total Revenue rose from $32.63 million in 2017 to $79.89 million in 2018, and that its Net Loss of $48.01 million in 2017 turned to a Net Income of $3.04 million in 2018.
On January 9, 2020, Innate Pharma S.A. announced its decision “to suspend enrollment of new patients” in its TELLOMAK Phase II trial evaluating the efficacy and safety of lacutamab (IPH4102) in patients with advanced T-cell lymphomas. Innate cited “ongoing discussions with regulatory authorities regarding Good Manufacturing Practice (GMP) deficiencies at the Company’s manufacturing subcontractor site that manages the fill and finish operations of the lacutamab clinical vials.”
Shares of Innate Pharma S.A. (NASDAQ: IPHA) declined from $8.24 per share on January 2, 2020 to as low as $6.70 per share on January 9, 2020
Those who purchased shares of Innate Pharma S.A. (NASDAQ: IPHA) have certain options and should contact the Shareholders Foundation.
Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investigation announced for Investors in shares of Innate Pharma S.A. (NASDAQ: IPHA) here
News-ID: 1897264 • Views: …
More Releases from Shareholders Foundation
ALERT: Lawsuit filed for Investors who SOLD shares of Sina Corporation (formerly …
An investor, who sold shares of Sina Corporation (formerly NASDAQ: SINA) in the merger between Seina Corporation and TuSimple Holdings, Inc, filed a lawsuit over alleged violations of Federal Securities Laws by Sina Corporation (formerly NASDAQ: SINA in connection with certain allegedly false and misleading statements made.
If you sold a significant amount of shares of Sina Corporation (formerly NASDAQ: SINA) between October 13, 2020 and March 22, 2021, you have…
Lawsuit Alert: Investors who lost money with shares of Fluor Corporation (NYSE: …
An investor, who purchased shares of Fluor Corporation (NYSE: FLR), filed a lawsuit alleged violations of Federal Securities Laws by Fluor Corporation in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Fluor Corporation (NYSE: FLR) have certain options and for certain investors are short and strict deadlines running. Deadline: November 14, 2025. NYSE: FLR investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779…
Investigation announced for Long-Term Investors in shares of Sable Offshore Corp …
An investigation was announced for long-term investors in shares of Sable Offshore Corp. (NYSE: SOC) concerning potential breaches of fiduciary duties by certain directors of Sable Offshore Corp.
Investors who are current long term investors in Sable Offshore Corp. (NYSE: SOC) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in…
Lawsuit filed for Investors who lost money with shares of Lantheus Holdings, Inc …
An investor, who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH), filed a lawsuit over alleged violations of Federal Securities Laws by Lantheus Holdings, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) have certain options and for certain investors are short and strict deadlines running. Deadline: November 10, 2025. NASDAQ: LNTH investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
More Releases for Innate
Sound Therapy Market Set for Rapid Expansion, New Report by 2025-2032 | Innate S …
The Sound Therapy Market : A thorough analysis of statistics about the current as well as emerging trends offers clarity regarding the Sound Therapy Market dynamics. The report includes Porter's Five Forces to analyze the prominence of various features such as the understanding of both the suppliers and customers, risks posed by various agents, the strength of competition, and promising emerging businesspersons to understand a valuable resource. Also, the report…
Innate Midwifery Launches Patient Referral Discount Program in Salt Lake Valley
SALT LAKE CITY, UT - Sep 1, 2025 - Innate Midwifery, a licensed maternity care provider based in Salt Lake City, has formally introduced a referral-based discount program intended to broaden access to midwifery services throughout the Salt Lake Valley. The program, now in effect, offers financial incentives to both referring clients and their referrals.
Image: https://www.globalnewslines.com/uploads/2025/08/3217874800f5d4dcf26bd3cd3362da7c.jpg
Under the structure of the new program, current or previous patients who refer someone to…
Sound Therapy Market Is Booming So Rapidly By 2032 | Innate Sounds, Sound Oasis, …
The Sound Therapy Market Research Report is the result of extensive research and analysis conducted by our team of experienced market researchers. It encompasses a wide range of critical factors influencing the Sound Therapy Market Growth from 2025 to 2032, including competitive landscape, consumer behavior, and technological advancements. This report serves as a valuable resource for industry players, helping them make informed decisions and stay ahead of the competition in…
Oropharyngeal Cancer Market Future Business Opportunities 2025-2032 |Innate Phar …
Latest Report, titled "Oropharyngeal Cancer Market" Trends, Share, Size, Growth, Opportunity and Forecast 2025-2032, by CoherentMI offers a comprehensive analysis of the industry, which comprises insights on the market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market.
The oropharyngeal cancer market is estimated to be valued at USD 2.11 Bn in 2024 and is expected to reach USD 3.05 Bn by 2031, growing at…
Lawsuit filed for Investors in shares of Innate Pharma S.A. (NASDAQ: IPHA)
An investor, who purchased shares of Innate Pharma S.A. (NASDAQ: IPHA), filed a lawsuit over alleged violations of Federal Securities Laws by Innate Pharma S.A..
Investors who purchased shares of Innate Pharma S.A. (NASDAQ: IPHA) have certain options and for certain investors are short and strict deadlines running. Deadline: December 22, 2020. NASDAQ: IPHA investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
France based Innate Pharma…
Walter Land: Crucial role of innate immune events in organ transplantation
"There is growing evidence that innate immune events provide critical initiating steps in immune responses to transplantation and key pathogenic steps in the tissue damage characteristic of humoral and cellular rejection. In fact, when I coined the term Innate Alloimmunity in 2002, I never foresaw the effect it would have on transplant thinking today," Professor Dr. Walter Land (Munich) emphasizes in his textbook "Innate Alloimmunity".
"This book reflects the beginning…
